Literature DB >> 16546322

The Ets transcription factors of the PEA3 group: transcriptional regulators in metastasis.

Yvan de Launoit1, Jean-Luc Baert, Anne Chotteau-Lelievre, Didier Monte, Laurent Coutte, Sébastien Mauen, Virginie Firlej, Cindy Degerny, Kathye Verreman.   

Abstract

The PEA3 group is composed of three highly conserved Ets transcription factors: Erm, Er81, and Pea3. These proteins regulate transcription of multiple genes, and their transactivating potential is affected by post-translational modifications. Among their target genes are several matrix metalloproteases (MMPs), which are enzymes degrading the extracellular matrix during normal remodelling events and cancer metastasis. In fact, PEA3-group genes are often over-expressed in different types of cancers that also over-express these MMPs and display a disseminating phenotype. Experimental regulation of the synthesis of PEA3 group members influences the metastatic process. This suggests that these factors play a key role in metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546322     DOI: 10.1016/j.bbcan.2006.02.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  61 in total

1.  Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation.

Authors:  Geetha Rao; Dingxie Liu; Mingzhao Xing; Jordi Tauler; Richard A Prinz; Xiulong Xu
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Gene expression signatures of site-specificity in cancer metastases.

Authors:  Franz Hartung; Aditya Patil; Rohan J Meshram; Georg F Weber
Journal:  Clin Exp Metastasis       Date:  2019-09-25       Impact factor: 5.150

Review 3.  Gradients in the brain: the control of the development of form and function in the cerebral cortex.

Authors:  Stephen N Sansom; Frederick J Livesey
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08       Impact factor: 10.005

4.  Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.

Authors:  Paula Paulo; Franclim R Ribeiro; Joana Santos; Diana Mesquita; Mafalda Almeida; João D Barros-Silva; Harri Itkonen; Rui Henrique; Carmen Jerónimo; Anita Sveen; Ian G Mills; Rolf I Skotheim; Ragnhild A Lothe; Manuel R Teixeira
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

5.  Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer.

Authors:  Said Rahim; Aykut Uren
Journal:  Am J Transl Res       Date:  2013-04-19       Impact factor: 4.060

6.  The ETS transcription factor Etv1 mediates FGF signaling to initiate proneural gene expression during Xenopus laevis retinal development.

Authors:  Minde Willardsen; David A Hutcheson; Kathryn B Moore; Monica L Vetter
Journal:  Mech Dev       Date:  2013-11-09       Impact factor: 1.882

7.  PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.

Authors:  Karen D Cowden Dahl; Reema Zeineldin; Laurie G Hudson
Journal:  Mol Cancer Res       Date:  2007-05-02       Impact factor: 5.852

8.  Role of the TMPRSS2-ERG gene fusion in prostate cancer.

Authors:  Scott A Tomlins; Bharathi Laxman; Sooryanarayana Varambally; Xuhong Cao; Jindan Yu; Beth E Helgeson; Qi Cao; John R Prensner; Mark A Rubin; Rajal B Shah; Rohit Mehra; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

9.  The small molecule phenamil is a modulator of adipocyte differentiation and PPARgamma expression.

Authors:  Kye Won Park; Hironori Waki; Sung-Pil Choi; Ki-Moon Park; Peter Tontonoz
Journal:  J Lipid Res       Date:  2010-06-02       Impact factor: 5.922

10.  Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis.

Authors:  Benson C Lu; Cristina Cebrian; Xuan Chi; Satu Kuure; Richard Kuo; Carlton M Bates; Silvia Arber; John Hassell; Lesley MacNeil; Masato Hoshi; Sanjay Jain; Naoya Asai; Masahide Takahashi; Kai M Schmidt-Ott; Jonathan Barasch; Vivette D'Agati; Frank Costantini
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.